Further physiological underpinning for gestational β-cell compensation stems from the clinical observations that pregnant women with long-standing type 1 diabetes experience a relatively higher rate of hypoglycemic episodes in the first trimester or have a significantly reduced daily insulin requirement along with better glycemic control during pregnancy (39). The gene discussed is INS; the disease is type 1 diabetes mellitus.